The Smad pathway in TGF-β signalling

Cellular and Molecular Biology Letters

Volumn 5, Issue 3, 2000, Pages 381-396

  Piestrzeniewicz, D ^a   Brys, M ^a   Krajewska, W M ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

Signal Transduction; Smads; TGF

Indexed keywords

MEMBRANE RECEPTOR; NUCLEAR FACTOR; SMAD PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CARCINOGENESIS; GENE TARGETING; PROTEIN DOMAIN; PROTEIN STRUCTURE; REACTION ANALYSIS; SIGNAL TRANSDUCTION;

EID: 0033761282     PISSN: 14258153     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (85)

1. The TGF-β superfamily: New members, new receptors, and new genetic tests of function in different organisms
2. Transforming growth factor-β, other growth factors, and the extracellular matrix
3. TGF-β signalling from cell membrane to nucleus through SMAD proteins
4. Mechanism and function of signaling by the TGFβ superfamily
5. Serine/threonine kinase receptors and ligands
6. Mads and Smads in TGFβ signalling
7. TGF-β signaling and cancer: Structural and functional consequences of mutations in Smads
8. Molecular mechanisms of transforming growth factor-β signaling
9. SMADs: Mediators and regulators of TGF-β signalling
10. TGF-β signal transduction
11. Signal Transduction of the TGF-β superfamily by Smad proteins
12. Genetic characterisation and cloning of Mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster
13. Caenorhabditis elegans genes sma2, sma-3, and sma-4 define a conserved family of transforming growth factor beta pathway components
14. 467 is required for Smad2/Smad4 complex formation and signalling
15. Crystal structure of a Smad MH1 domain bound to DNA: Insights on DNA binding in TGF-β signalling
16. Human Smad3 and Smad4 are sequence-specific transcription activators
17. Interaction of Smad complexes with tripartite DNA-binding sites
18. Alternatively spliced variant of Smad2 lacking exon 3
19. Structural basis of Smad2 recognition by the Smad anchor for receptor activation
20. A structural basis for mutational inactivation of the tumour suppressor Smad4
21. Characterization of functional domains within Smad4/DPC4
22. The Smad4 Activation Domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain
23. The L3 loop: A structural motif determining specific interactions between SMAD proteins and TGF-β receptors
24. Determinants of specifity in TGF-β signal transduction
25. A molecular basis for Smad specificity
26. Smad4 and FAST-1 in the assembly of activin-responsive factor
27. 467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor -β signalling
28. SARA, a FYVE domain protein that recruits Smad2 to the TGFβ receptor
29. Intracellular signaling: Fleshing out the TGFβ pathway
30. The MAD-related protein Smad7 Associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling
31. Smad6 inhibits signalling by the TGF-β superfamily
32. Identification of Smad7, a TGF-β inducible antagonist of TGF-β signalling
33. Can't get no SMADisfaction: Smad proteins as positive and negative regulators of TGF-β family signals
34. Smad6 inhibits BMP/Smad1 signalling by specifically competing with the Smad4 tumour suppressor
35. Smads: Transcriptional activators of TGF-β Responses
36. A transcriptional partner for Mad proteins in TGF-β signalling
37. Dual role of the Smad4/DPC4 tumor suppressor in TGF-β-inducible transcriptional complexes
38. Smad2 and Smad3 positively and negatively regulate TGFβ-dependent transcription trough the forkhead DNA-binding protein FAST2
39. Smad3 inhibits transforming growth factor-β and activin signaling by competing with Smad4 for FAST-2 binding
40. Smads bind directly to the Jun family of AP-1 transcription factors
41. Synergistic cooperation of TFE3 and Smad proteins in TGF-β-induced transcription of the plasminogen activator inhibitor-1 gene
42. Specifity in transforming growth factor β-induced transcription of the plasminogen activator inhibitor-1 gene: Interactions of promoter DNA, transcription factor μE3, and Smad proteins
43. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members
44. Interaction and functional cooperation of PEBP2/CBF with Smads
45. Multiple modes of repression by the Smad transcriptional corepressor TGIF
46. SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5'-CACCT sequences in candidate target genes
47. c-Ski acts as a transcriptional co-repressor in transforming growth factor-β signaling through interactions with Smads
48. The ski oncoprotein interacts with the Smad proteins to repress TGF beta signaling
49. Negative feedback regulation of TGF-β signaling by the SnoN oncoprotein
50. SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor β signaling
51. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for Smad3 in TGF-β-induced transcriptional activation
52. TGF-β-stimulated cooperation of Smad proteins with the coactivators CBP/p300
53. Physical and functional interaction of SMADs and p300/CBP
54. TGF-β-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein
55. Transcriptional activating activity of Smad4: Roles of SMAD heterooligomerization and enhancement by an associating transactivator
56. A Smad transcriptional corepressor
57. E1A inhibits transforming growth factor-β signaling through binding to Smad proteins
58. The oncoprotein Evi-1 represses TGF-β signalling by inhibiting Smad3
59. MDM2 and MDMX inhibit the transcriptional activity of ectopically expressed SMAD proteins
60. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma
61. DPC4, a candidate tumor supressor gene at human chromosome 18q21.1
62. Mad-related genes in human
63. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4
64. Frequency of Smad gene mutations in human cancers
65. Screening SMAD1, SMAD2, SMAD3, and SMAD5 for germline mutations in juvenile polyposis syndrome
66. Identification of Smad2, a human Mad-related protein in the transforming growth factor β signaling pathway
67. Characterization of the MADH2/Smad2 gene, a human Mad homolog responsible for the Transforming growth factor-β and Activin signal transduction pathway
68. Somatic alterations of the SMAD-2 gene in human colorectal cancers
69. Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers
70. Smad2 and Smad4 gene mutations in hepatocellular carcinoma
71. Evidence that Smad2 is a tumor suppressor implicated in the control of cellular invasion
72. Smad4 (DPC4)-a potent tumour suppressor
73. Molecular analyses of the 15q and 18q SMAD genes in pancreatic cancer
74. DPC4 gene in various tumor types
75. Involvement of mutations in the DPC4 promoter in endometrial carcinoma development
76. Comparative mutations analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas
77. Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers
78. DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma
79. Infrequent DPC4 gene mutation in esophageal cancer, gastric cancer and ulcerative colitis-associated neoplasms
80. Analysis of the DPC4 gene in gastric carcinoma
81. Somatic alterations of the DPC4 gene in human colorectal cancers in vivo
82. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis
83. Direct genetic testing for Smad4 mutations in patients at risk for juvenile polyposis
84. SMAD genes in juvenile polyposis
85. Dpc4 transcriptional activation and dysfunction in cancer cells